|
|
重症社区获得性肺炎病原学及检测技术研究进展
|
Abstract:
重症社区获得性肺炎(SCAP)是社区获得性肺炎(CAP)中最威胁生命的一种，其特征是高发病率和死亡率。在临床实践中，CAP的微生物病因往往不清楚，不同的研究有不同的报道结果。随着时间的发展，病原微生物谱也发生了很大的变化。然而，在SCAP中，确定病因是调整抗生素治疗的基石。近年来随着检测技术的进展，越来越多的病原微生物被检出，为指导临床治疗提供了极大的帮助。本片综述主要对近几年来，SCAP病原学变化及检测技术进展进行相应的描述。
Severe community pneumonia (SCAP) is one of the most life-threatening types of community pneumonia (CAP), which is characterized by high morbidity and mortality. In clinical practice, the microbial etiology of CAP is often unclear, and different studies have different reported results. The spectrum of pathogenic microorganisms also changed greatly with time. However, determining the etiology in SCAP is the cornerstone of antibiotic treatment. In recent years, with the development of detection technology, more and more pathogenic microorganisms have been detected, which provides great help for guiding clinical treatment. This review mainly describes the pathogen changes and detection technology progress of SCAP in recent years.
| [1] | Mandell, L.A. (2015) Community-Acquired Pneumonia: An Overview. Postgraduate Medicine, 127, 607-615. https://doi.org/10.1080/00325481.2015.1074030 |
| [2] | 刘娟, 等. 儿童社区获得性肺炎的病原菌及耐药性变迁[J]. 临床研究, 2021, 29(10): 7-10. |
| [3] | 韩佳佳. 血清STREM-1、PCT、CRP水平联合PSI、CURB65评分在重症肺炎诊断中的价值研究[D]: [硕士学位论文]. 延安: 延安大学, 2023. |
| [4] | Martin-Loeches, I. and Torres, A. (2021) New Guidelines for Severe Community-Acquired Pneumonia. Current Opinion in Pulmonary Medicine, 27, 210-215. https://doi.org/10.1097/MCP.0000000000000760 |
| [5] | Wilson, P.A. and Ferguson, J. (2005) Severe Community-Acquired Pneumonia: An Australian Perspective. Internal Medicine Journal, 35, 699-705. https://doi.org/10.1111/j.1445-5994.2005.00962.x |
| [6] | 张雅楠. 急诊重症社区获得性肺炎患者病原学特点及感染相关标志物的观察[D]: [硕士学位论文]. 天津: 天津医科大学, 2020. |
| [7] | Niederman, M.S. and Torres, A. (2022) Severe Community-Acquired Pneumonia. European Respiratory Review, 31, Article ID: 220123. https://doi.org/10.1183/16000617.0123-2022 |
| [8] | Tsai, D., Chiong, F., Secombe, P., et al. (2022) Epidemiologyand Microbiologyof Severe Community-Acquired Pneumonia in Central Australia: A Retrospective Study. Internal Medicine Journal, 52, 1048-1056. https://doi.org/10.1111/imj.15171 |
| [9] | Feldman, C. (1997) Severe Community-Acquired Pneumonia. Current Opinion in Pulmonary Medicine, 3, 98-104. https://doi.org/10.1097/00063198-199703000-00003 |
| [10] | 曾永保, 何林波, 尹春梅, 等. 283例重症社区获得性肺炎患者支气管肺泡灌洗液病原菌分布及药敏分析[J]. 药物流行病学杂志, 2017, 26(7): 485-489. |
| [11] | 刘玉玲. 44例重症社区获得性肺炎的临床分析[D]: [硕士学位论文]. 郑州: 郑州大学, 2013. |
| [12] | Wiemken, T., Peyrani, P., Bryant, K., et al. (2013) Incidence of Respiratory Viruses in Patients with Community-Acquired Pneumonia Admitted to the Intensive Care Unit: Results from the Severe Influenza Pneumonia Surveillance (SIPS) Project. European Journal of Clinical Microbiology & Infectious Diseases, 32, 705-710. https://doi.org/10.1007/s10096-012-1802-8 |
| [13] | Choi, S.H., Hong, S.B., Ko, G.B., et al. (2012) Viral Infection in Patients with Severe Pneumonia Requiring Intensive Care Unit Admission. American Journal of Respiratory and Critical Care Medicine, 186, 325-332. https://doi.org/10.1164/rccm.201112-2240OC |
| [14] | Wang, J. and Song, Y.L. (2019) Advances in Severe Community-Acquired Pneumonia. Chinese Medical Journal, 132, 1891-1893. https://doi.org/10.1097/CM9.0000000000000366 |
| [15] | Nair, G.B. and Niederman, M.S. (2021) Updates on Community Acquired Pneumonia Management in the ICU. Pharmacology & Therapeutics, 217, Article ID: 107663. https://doi.org/10.1016/j.pharmthera.2020.107663 |
| [16] | Leoni, D. and Rello, J. (2017) Severe Community-Acquired Pneumonia: Optimal Management. Current Opinion in Infectious Diseases, 30, 240-247. https://doi.org/10.1097/QCO.0000000000000349 |
| [17] | 单梦洁. 鼻病毒分子流行特征及其在社区获得性肺炎中病原学作用的研究[D]: [硕士学位论文]. 北京: 中国医学科学院北京协和医学院, 2020. |
| [18] | Khawaja, A., Zubairi, A.B., Durranl, F.K., et al. (2013) Etiology and Outcome of Severe Community Acquired Pneumonia in Immunocompetent Adults. BMC Infectious Diseases, 13, Article No. 94. https://doi.org/10.1186/1471-2334-13-94 |
| [19] | Ruiz, M., Ewig, S., Torres, A., et al. (1999) Severe Community-Acquired Pneumonia. Risk Factors and Follow-Up Epidemiology. American Journal of Respiratory and Critical Care Medicine, 160, 923-929. https://doi.org/10.1164/ajrccm.160.3.9901107 |
| [20] | 鲍中英, 苑晓冬, 王蕾. 402例社区获得性肺炎的发病状况及病原学分析[J]. 中华全科医学, 2013, 11(3): 362-363. |
| [21] | Liu, Y.N., Zhang, Y.F., Xu, Q., et al. (2023) Infection and Co-Infection Patterns of Community-Acquired Pneumonia in Patients of Different Ages in China from 2009 to 2020: A National Surveillance Study. The Lancet Microbe, 4, E330-E339. https://doi.org/10.1016/S2666-5247(23)00031-9 |
| [22] | 陈红光, 俞喆珺. 某院119例重症社区获得性肺炎患者的病原学特点与发生死亡的危险因素分析[J]. 抗感染药学, 2023, 20(5): 525-530. |
| [23] | Ewig, S. and Torres, A. (2002) Severe Community-Acquired Pneumonia. Current Opinion in Critical Care, 8, 453-460. https://doi.org/10.1097/00075198-200210000-00014 |
| [24] | Klein, M., Bacher, J., Barth, S., et al. (2021) Multicenter Evaluation of the Unyvero Platform for Testing Bronchoalveolar Lavage Fluid. Journal of Clinical Microbiology, 59, Article e02497-20. https://doi.org/10.1128/JCM.02497-20 |
| [25] | Peng, Z., Zhou, J. and Tian, L. (2020) Pathogenic Characteristics of Sputum and Bronchoalveolar Lavage Fluid Samples from Patients with Lower Respiratory Tract Infection in a Large Teaching Hospital in China: A Retrospective Study. BMC Pulmonary Medicine, 20, Article No. 233. https://doi.org/10.1186/s12890-020-01275-8 |
| [26] | Bluth, M.J. and Bluth, M.H. (2018) Molecular Pathology Techniques: Advances in 2018. Clinics in Laboratory Medicine, 38, 215-236. https://doi.org/10.1016/j.cll.2018.03.004 |
| [27] | Kurutepe, S., Ecemis, T., Ozgen, A., et al. (2012) [Investigation of Bacterial Etiology with Conventional and Multiplex PCR Methods in Adult Patients with Community-Acquired Pneumonia]. Mikrobiyoloji Bülteni, 46, 523-531. |
| [28] | Mustafa, M.I., AI-Marzooq, F., How, S H., et al. (2011) The Use of Multiplex Real-Time PCR Improves the Detection of the Bacterial Etiology of Community Acquired Pneumonia. Tropical Biomedicine, 28, 531-544. |
| [29] | Liu, H., Zhang, Y., Chen, G., et al. (2022) Diagnostic Significance of Metagenomic Next-Generation Sequencing for Community-Acquired Pneumonia in Southern China. Frontiers in Medicine, 9, Article 807174. https://doi.org/10.3389/fmed.2022.807174 |
| [30] | Wei, Y., Zhang, T., Ma, Y., et al. (2023) Clinical Evaluation of Metagenomic Next-Generation Sequencing for the Detection of Pathogens in BALF in Severe Community Acquired Pneumonia. Italian Journal of Pediatrics, 49, Article No. 25. https://doi.org/10.1186/s13052-023-01431-w |
| [31] | Chen, H., Yin, Y., Gao, Y., et al. (2020) Clinical Utility of In-House Metagenomic Next-Generation Sequencing for the Diagnosis of Lower Respiratory Tract Infections and Analysis of the Host Immune Response. Clinical Infectious Diseases, 71, S416-S426. https://doi.org/10.1093/cid/ciaa1516 |
| [32] | Lin, T., Tu, X., Zhao, J., et al. (2023) Microbiological Diagnostic Performance of Metagenomic Next-Generation Sequencingcompared with Conventional Culture for Patients with Community-Acquired Pneumonia. Frontiers in Cellular and Infection Microbiology, 13, Article 1136588. https://doi.org/10.3389/fcimb.2023.1233180 |
